What Will Happen to Cogentix Medical Inc (CGNT) Next? The Stock Just Increased A Lot

September 4, 2017 - By Migdalia James

The stock of Cogentix Medical Inc (NASDAQ:CGNT) is a huge mover today! The stock increased 4.35% or $0.1 on September 1, reaching $2.4. About 109,384 shares traded or 85.65% up from the average. Cogentix Medical Inc (NASDAQ:CGNT) has risen 83.33% since September 4, 2016 and is uptrending. It has outperformed by 66.63% the S&P500.
The move comes after 5 months positive chart setup for the $146.20M company. It was reported on Sep, 4 by Barchart.com. We have $2.57 PT which if reached, will make NASDAQ:CGNT worth $10.23 million more.

Cogentix Medical Inc (NASDAQ:CGNT) Ratings Coverage

Among 2 analysts covering Cogentix Medical (NASDAQ:CGNT), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cogentix Medical had 5 analyst reports since November 5, 2015 according to SRatingsIntel. Roth Capital upgraded Cogentix Medical Inc (NASDAQ:CGNT) on Thursday, November 5 to “Buy” rating. The firm earned “Buy” rating on Wednesday, August 2 by Roth Capital. TH Capital upgraded it to “Buy” rating and $3 target in Thursday, November 5 report. On Friday, May 6 the stock rating was downgraded by Roth Capital to “Neutral”. On Tuesday, July 18 the stock rating was maintained by Roth Capital with “Buy”.

More notable recent Cogentix Medical Inc (NASDAQ:CGNT) news were published by: Seekingalpha.com which released: “Cogentix buys Genesis Medical” on July 26, 2017, also Prnewswire.com with their article: “Ash Keswani Joins Cogentix Medical as SVP of Marketing and Business Development” published on April 20, 2017, Prnewswire.com published: “Cogentix Medical to Report First Quarter Results on May 2, 2017” on April 18, 2017. More interesting news about Cogentix Medical Inc (NASDAQ:CGNT) were released by: Prnewswire.com and their article: “Cogentix Medical Reports Strong Second Quarter Operating Results with 11 …” published on August 01, 2017 as well as Prnewswire.com‘s news article titled: “Cogentix Medical Signs Agreement to Launch Endo-Urology Product Line in US …” with publication date: July 18, 2017.

Cogentix Medical, Inc. is a global medical device company. The company has market cap of $146.20 million. The Firm designs, develops, makes and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. It currently has negative earnings. The Firm also offers the Urgent PC Neuromodulation System , a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office treatment of overactive bladder (OAB).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.